ResMed Inc.
RMD
$251.69
$3.111.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.48% | 65.05% | 41.90% | 27.25% | 29.24% |
| Total Depreciation and Amortization | -4.67% | 6.59% | 1.72% | -0.45% | 4.47% |
| Total Amortization of Deferred Charges | -7.34% | -7.62% | -7.61% | -3.26% | -2.82% |
| Total Other Non-Cash Items | 383.90% | -57.59% | -13.62% | 131.32% | -47.56% |
| Change in Net Operating Assets | 224.10% | -163.72% | -519.52% | 190.69% | 384.95% |
| Cash from Operations | 43.93% | 13.12% | 13.71% | 85.36% | 42.28% |
| Capital Expenditure | 1.86% | 11.60% | 40.60% | 27.77% | 26.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 91.07% | -- | -1,192.45% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.73% | -49.52% | 226.80% | 81.70% | -1,345.72% |
| Cash from Investing | 4.12% | 10.82% | 101.44% | 0.03% | -17.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 96.15% | 83.78% | -106.90% | -2.33% |
| Issuance of Common Stock | 84.44% | 37.66% | 752.80% | 17.89% | 397.66% |
| Repurchase of Common Stock | -49.84% | -58.67% | -22,297.33% | -14,997.31% | -8,515.41% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.23% | -9.93% | -10.33% | -9.04% | -9.05% |
| Other Financing Activities | -- | -- | 33.87% | 100.00% | 100.00% |
| Cash from Financing | 57.11% | 38.26% | 0.25% | -108.54% | -20.16% |
| Foreign Exchange rate Adjustments | 250.19% | -442.32% | 323.16% | 105.55% | -2,436.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,384.90% | 8,233.30% | 1,100.48% | 15,133.33% | 209.32% |